Antibacterial and antibiofilm effects of iron chelators against Prevotella intermedia

Journal of Medical Microbiology

Volumn 62, Issue , 2013, Pages 1307-1316

  Moon, Ji Hoi ^a   Kim, Cheul ^c   Lee, Hee Su ^c   Kim, Sung Woon ^b   Lee, Jin Yong ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Gangneung Wonju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; DEFERASIROX; DEFEROXAMINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOFILM ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOFILM; GROWTH INHIBITION; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPE;

ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; BENZOATES; BIOFILMS; CHELATING AGENTS; DEFEROXAMINE; IRON; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PREVOTELLA INTERMEDIA; TRIAZOLES;

EID: 84881566424     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.053553-0     Document Type: Article

References (84)

1. Albandar, J. M., Brown, L. J. & Löe, H. (1997). Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis. J Periodontol 68, 973-981.
2. Andrés, M. T., Chung, W. O., Roberts, M. C. & Fierro, J. F. (1998). Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrob Agents Chemother 42, 3022-3023.
3. Ardila, C. M., Granada, M. I. & Guzmán, I. C. (2010). Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res 45, 557-563.
4. Ashimoto, A., Chen, C., Bakker, I. & Slots, J. (1996). Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 11, 266-273.
5. Bentur, Y., McGuigan, M. & Koren, G. (1991). Deferoxamine (desferrioxamine). New toxicities for an old drug. Drug Saf 6, 37-46.
6. Brook, I. & Frazier, E. H. (2003). Immune response to Fusobacterium nucleatum and Prevotella intermedia in the sputum of patients with acute exacerbation of chronic bronchitis. Chest 124, 832-833.
7. Cable, H. & Lloyd, J. B. (1999). Cellular uptake and release of two contrasting iron chelators. J Pharm Pharmacol 51, 131-134.
8. Cappellini, M. D. (2007). ExjadeR (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion. Ther Clin Risk Manag 3, 291-299.
9. Chan, G. C., Chan, S., Ho, P. L. & Ha, S. Y. (2009). Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients. Hemoglobin 33, 352-360.
10. Chong, A., Wehrly, T. D., Nair, V., Fischer, E. R., Barker, J. R., Klose, K. E. & Celli, J. (2008). The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect Immun 76, 5488-5499.
11. Clark, W. B., Magnusson, I., Beem, J. E., Jung, J. M., Marks, R. G. & McArthur, W. P. (1991). Immune modulation of Prevotella intermedia colonization in squirrel monkeys. Infect Immun 59, 1927-1931.
12. CLSI (2007). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard, 7th edn. Document M11-A7. Wayne, PA: Clinical and Laboratory Standards Institute.
13. Denny, T. P., Makini, F. W. & Brumbley, S. M. (1988). Characterization of Pseudomonas solanacearum Tn5 mutants deficient in extracellular polysaccharide. Mol Plant Microbe Interact 1, 215-223.
14. Dong, L., Tong, Z., Linghu, D., Lin, Y., Tao, R., Liu, J., Tian, Y. & Ni, L. (2012). Effects of sub-minimum inhibitory concentrations of antimicrobial agents on Streptococcus mutans biofilm formation. Int J Antimicrob Agents 39, 390-395.
15. Donlan, R. M. (2002). Biofilms: microbial life on surfaces. Emerg Infect Dis 8, 881-890.
16. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167-193.
17. Eckert, R., He, J., Yarbrough, D. K., Qi, F., Anderson, M. H. & Shi, W. (2006). Targeted killing of Streptococcus mutans by a pheromoneguided "smart" antimicrobial peptide. Antimicrob Agents Chemother 50, 3651-3657.
18. Escartin, Q., Lallam-Laroye, C., Baroukh, B., Morvan, F. O., Caruelle, J. P., Godeau, G., Barritault, D. & Saffar, J. L. (2003). A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers. FASEB J 17, 644-651.
19. Fiehn, N. E., Larsen, T., Christiansen, N., Holmstrup, P. & Schroeder, T. V. (2005). Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 76, 731-736.
20. Fosse, T., Madinier, I., Hannoun, L., Giraud-Morin, C., Hitzig, C., Charbit, Y. & Ourang, S. (2002). High prevalence of cfxA b-lactamase in aminopenicillin-resistant Prevotella strains isolated from periodontal pockets. Oral Microbiol Immunol 17, 85-88.
21. Frank, K. L., Reichert, E. J., Piper, K. E. & Patel, R. (2007). In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother 51, 888-895.
22. Fux, C. A., Stoodley, P., Hall-Stoodley, L. & Costerton, J. W. (2003). Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther 1, 667-683.
23. Gibbons, R. J. & MacDonald, J. B. (1960). Hemin and vitamin K compounds as required factors for the cultivation of certain strains of Bacteroides melaninogenicus. J Bacteriol 80, 164-170.
24. Glickstein, H., El, R. B., Shvartsman, M. & Cabantchik, Z. I. (2005). Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. Blood 106, 3242-3250.
25. Halliday, J. W. & Bassett, M. L. (1980). Treatment of iron storage disorders. Drugs 20, 207-215.
26. Hanson, L. R., Roeytenberg, A., Martinez, P. M., Coppes, V. G., Sweet, D. C., Rao, R. J., Marti, D. L., Hoekman, J. D., Matthews, R. B. & other authors (2009). Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther 330, 679-686.
27. Hassan, A., Usman, J., Kaleem, F., Omair, M., Khalid, A. & Iqbal, M. (2011). Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 15, 305-311.
28. Heinz, U., Hegetschweiler, K., Acklin, P., Faller, B., Lattmann, R. & Schnebli, H. P. (1999). 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid: a novel efficient and selective iron(III) complexing agent. Angew Chem Int Ed Engl 38, 2568-2570.
29. Hershko, C., Konijn, A. M., Nick, H. P., Breuer, W., Cabantchik, Z. I. & Link, G. (2001). ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture. Blood 97, 1115-1122.
30. Hershko, C., Link, G., Konijn, A. M. & Cabantchik, Z. I. (2005). Objectives and mechanism of iron chelation therapy. Ann N Y Acad Sci 1054, 124-135.
31. Honma, K., Mishima, E., Inagaki, S. & Sharma, A. (2009). The OxyR homologue in Tannerella forsythia regulates expression of oxidative stress responses and biofilm formation. Microbiology 155, 1912-1922.
32. Kamma, J. J., Nakou, M., Gmür, R. & Baehni, P. C. (2004). Microbiological profile of early onset/aggressive periodontitis patients. Oral Microbiol Immunol 19, 314-321.
33. Kontoghiorghes, G. J., Kolnagou, A., Skiada, A. & Petrikkos, G. (2010). The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies. Hemoglobin 34, 227-239.
34. Kuru, B., Yilmaz, S., Noyan, U., Acar, O. & Kadir, T. (1999). Microbiological features and crevicular fluid aspartate aminotransferase enzyme activity in early onset periodontitis patients. J Clin Periodontol 26, 19-25.
35. Lauzon, K., Zhao, X. & Lacasse, P. (2006). Deferoxamine reduces tissue damage during endotoxin-induced mastitis in dairy cows. J Dairy Sci 89, 3846-3857.
36. Lesic, B., Foulon, J. & Carniel, E. (2002). Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica. Antimicrob Agents Chemother 46, 1741-1745.
37. Leung, K. P., Subramaniam, P. S., Okamoto, M., Fukushima, H. & Lai, C. H. (1998). The binding and utilization of hemoglobin by Prevotella intermedia. FEMS Microbiol Lett 162, 227-233.
38. Lewis, J. P. (2010). Metal uptake in host-pathogen interactions: role of iron in Porphyromonas gingivalis interactions with host organisms. Periodontol 2000 52, 94-116.
39. Lewis, J. P., Dawson, J. A., Hannis, J. C., Muddiman, D. & Macrina, F. L. (1999). Hemoglobinase activity of the lysine gingipain protease (Kgp) of Porphyromonas gingivalis W83. J Bacteriol 181, 4905-4913.
40. Liu, Z. D. & Hider, R. C. (2002). Design of iron chelators with therapeutic application. Coord Chem Rev 232, 151-171.
41. Mah, T. F. & O'Toole, G. A. (2001). Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9, 34-39.
42. McKenney, D., Willcock, L., Trueman, P. A. & Allison, D. G. (1994). Effect of sub-MIC antibiotics on the cell surface and extracellular virulence determinants of Pseudomonas cepacia. J Appl Bacteriol 76, 190-195.
43. Moon, J. H., Herr, Y., Kim, S. W. & Lee, J. Y. (2011a). In vitro activity of deferoxamine against Porphyromonas gingivalis. FEMS Microbiol Lett 323, 61-67.
44. Moon, J. H., Park, J. H. & Lee, J. Y. (2011b). Antibacterial action of polyphosphate on Porphyromonas gingivalis. Antimicrob Agents Chemother 55, 806-812.
45. Moreau-Marquis, S., O'Toole, G. A. & Stanton, B. A. (2009). Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells. Am J Respir Cell Mol Biol 41, 305-313.
46. Nakao, R., Senpuku, H. & Watanabe, H. (2006). Porphyromonas gingivalis galE is involved in lipopolysaccharide O-antigen synthesis and biofilm formation. Infect Immun 74, 6145-6153.
47. NCCLS (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline. Document M26-A. Wayne, PA: National Committee for Clinical Laboratory Standards.
48. Nick, H., Wong, A., Acklin, P., Faller, B., Jin, Y., Lattmann, R., Sergejew, T., Hauffe, S., Thomas, H. & Schnebli, H. P. (2002). ICL670A: preclinical profile. Adv Exp Med Biol 509, 185-203.
49. Novak, M. J. (1999). Necrotizing ulcerative periodontitis. Ann Periodontol 4, 74-78.
50. Olson, M. E., Ceri, H., Morck, D. W., Buret, A. G. & Read, R. R. (2002). Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 66, 86-92.
51. Palmer, R. J., Darveau, R., Lamont, R. J., Nyvad, B. & Teles, R. P. (2011). Human oral bacterial biofilms: composition, dynamics, and pathogenesis. In Biofilm Infections, pp. 35-68. Edited by T. Bjarnsholt, P. Ø. Jensen, C. Moser & N. Høiby. New York: Springer.
52. Petit, M. D., van Steenbergen, T. J., Timmerman, M. F., de Graaff, J. & van der Velden, U. (1994). Prevalence of periodontitis and suspected periodontal pathogens in families of adult periodontitis patients. J Clin Periodontol 21, 76-85.
53. Pine, L. & Boone, C. J. (1967). Comparative cell wall analyses of morphological forms within the genus Actinomyces. J Bacteriol 94, 875-883.
54. Polson, A. M., Garrett, S., Stoller, N. H., Bandt, C. L., Hanes, P. J., Killoy, W. J., Southard, G. L., Duke, S. P., Bogle, G. C. & other authors (1997). Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results. J Periodontol 68, 119-126.
55. Qu, Y., Daley, A. J., Istivan, T. S., Rouch, D. A. & Deighton, M. A. (2010). Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. J Antimicrob Chemother 65, 1405-1411.
56. Rao, R. S., Karthika, R. U., Singh, S. P., Shashikala, P., Kanungo, R., Jayachandran, S. & Prashanth, K. (2008). Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol 26, 333-337.
57. Rice, L. B. (2006). Antimicrobial resistance in gram-positive bacteria. Am J Med 119 (Suppl 1), S11-S19, discussion S62-S70.
58. Richardson, D. R. & Ponka, P. (1998). Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism. Am J Hematol 58, 299-305.
59. Richardson, D., Ponka, P. & Baker, E. (1994). The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res 54, 685-689.
60. Rowland, R. W., Mestecky, J., Gunsolley, J. C. & Cogen, R. B. (1993). Serum IgG and IgM levels to bacterial antigens in necrotizing ulcerative gingivitis. J Periodontol 64, 195-201.
61. Shibata, Y., Hiratsuka, K., Hayakawa, M., Shiroza, T., Takiguchi, H., Nagatsuka, Y. & Abiko, Y. (2003). A 35-kDa co-aggregation factor is a hemin binding protein in Porphyromonas gingivalis. Biochem Biophys Res Commun 300, 351-356.
62. Shinzato, T. & Saito, A. (1994). A mechanism of pathogenicity of "Streptococcus milleri group" in pulmonary infection: synergy with an anaerobe. J Med Microbiol 40, 118-123.
63. Smalley, J. W., Silver, J., Marsh, P. J. & Birss, A. J. (1998a). The periodontopathogen Porphyromonas gingivalis binds iron protoporphyrin IX in the m-oxo dimeric form: an oxidative buffer and possible pathogenic mechanism. Biochem J 331, 681-685.
64. Smalley, J. W., Birss, A. J., McKee, A. S. & Marsh, P. D. (1998b). Hemin regulation of hemoglobin binding by Porphyromonas gingivalis. Curr Microbiol 36, 102-106.
65. Smalley, J. W., Silver, J., Birss, A. J., Withnall, R. & Titler, P. J. (2003). The haem pigment of the oral anaerobes Prevotella nigrescens and Prevotella intermedia is composed of iron(III) protoporphyrin IX in the monomeric form. Microbiology 149, 1711-1718.
66. Smith, A. W. (2005). Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev 57, 1539-1550.
67. Soukos, N. S., Som, S., Abernethy, A. D., Ruggiero, K., Dunham, J., Lee, C., Doukas, A. G. & Goodson, J. M. (2005). Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother 49, 1391-1396.
68. Sritharan, M. (2006). Iron and bacterial virulence. Indian J Med Microbiol 24, 163-164.
69. Stewart, P. S. & Costerton, J. W. (2001). Antibiotic resistance of bacteria in biofilms. Lancet 358, 135-138.
70. Takahashi, N., Ishihara, K., Kimizuka, R., Okuda, K. & Kato, T. (2006). The effects of tetracycline, minocycline, doxycycline and ofloxacin on Prevotella intermedia biofilm. Oral Microbiol Immunol 21, 366-371.
71. Tenover, F. C. (2006). Mechanisms of antimicrobial resistance in bacteria. Am J Med 119 (Suppl 1), S3-S10, discussion S62-S70.
72. Tompkins, G. R., Wood, D. P. & Birchmeier, K. R. (1997). Detection and comparison of specific hemin binding by Porphyromonas gingivalis and Prevotella intermedia. J Bacteriol 179, 620-626.
73. van Asbeck, B. S., Marcelis, J. H., Marx, J. J. M., Struyvenberg, A., van Kats, J. H. & Verhoef, J. (1983). Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid. Eur J Clin Microbiol 2, 426-431.
74. van Asbeck, B. S., Marx, J. J., Struyvenberg, A., van Kats, J. H. & Verhoef, J. (1984). Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes. Blood 63, 714-720.
75. Vulcano, M., Meiss, R. P. & Isturiz, M. A. (2000). Deferoxamine reduces tissue injury and lethality in LPS-treated mice. Int J Immunopharmacol 22, 635-644.
76. Webb, M. (1953). Effects of magnesium on cellular division in bacteria. Science 118, 607-611.
77. Weinberg, K. (1990). Novel uses of deferoxamine. Am J Pediatr Hematol Oncol 12, 9-13.
78. Weiss, H. M., Fresneau, M., Camenisch, G. P., Kretz, O. & Gross, G. (2006). In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670]2 for rat, marmoset, rabbit, mouse, dog, and human. Drug Metab Dispos 34, 971-975.
79. Wills, A. P. & Chan, E. C. (1978). Morphogenetic expression of Arthrobacter globiformis 425 in continuous culture with carbon or biotin limitation. Can J Microbiol 24, 28-30.
80. Yamanaka, T., Furukawa, T., Matsumoto-Mashimo, C., Yamane, K., Sugimori, C., Nambu, T., Mori, N., Nishikawa, H., Walker, C. B. & other authors (2009). Gene expression profile and pathogenicity of biofilm-forming Prevotella intermedia strain 17. BMC Microbiol 9, 11.
81. Yamanaka, T., Yamane, K., Furukawa, T., Matsumoto-Mashimo, C., Sugimori, C., Nambu, T., Obata, N., Walker, C. B., Leung, K. P. & Fukushima, H. (2011). Comparison of the virulence of exopolysaccharide-producing Prevotella intermedia to exopolysaccharide nonproducing periodontopathic organisms. BMC Infect Dis 11, 228.
82. Young, K. D. (2006). The selective value of bacterial shape. Microbiol Mol Biol Rev 70, 660-703.
83. Yu, F., Anaya, C. & Lewis, J. P. (2007). Outer membrane proteome of Prevotella intermedia 17: identification of thioredoxin and ironrepressible hemin uptake loci. Proteomics 7, 403-412.
84. Zhang, L. & Mah, T. F. (2008). Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190, 4447-4452.